0001193125-23-103987.txt : 20230418 0001193125-23-103987.hdr.sgml : 20230418 20230417203356 ACCESSION NUMBER: 0001193125-23-103987 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230417 FILED AS OF DATE: 20230418 DATE AS OF CHANGE: 20230417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alvotech CENTRAL INDEX KEY: 0001898416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 981629342 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41421 FILM NUMBER: 23825228 BUSINESS ADDRESS: STREET 1: 9, RUE DE BITBOURG CITY: LUXEMBOURG STATE: N4 ZIP: L-1273 BUSINESS PHONE: 354 422-4500 MAIL ADDRESS: STREET 1: 9, RUE DE BITBOURG CITY: LUXEMBOURG STATE: N4 ZIP: L-1273 FORMER COMPANY: FORMER CONFORMED NAME: Alvotech Lux Holdings S.A.S. DATE OF NAME CHANGE: 20211209 6-K 1 d460745d6k.htm 6-K 6-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of April 2023

Commission File Number: 001-41421

 

 

Alvotech

(Translation of registrant’s name into English)

 

 

9, Rue de Bitbourg,

L-1273 Luxembourg,

Grand Duchy of Luxembourg

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒  Form 20-F            ☐  Form 40-F

 

 

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

Announcement

Alvotech has been informed by the U.S. Food and Drug Administration (FDA) that the responses provided to the FDA Form 483 on April 3, 2023, following the conclusion of the reinspection of the company’s Reykjavik facility on March 17, 2023, are currently under review.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

   

ALVOTECH

Date: April 17, 2023

    

By:

  

/s/ Tanya Zharov

     

Name: Tanya Zharov

     

Title: General Counsel